high-density lipoprotein delipidation therapy (Lipid Sciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehigh-density lipoprotein delipidation therapy (Lipid Sciences)
Drug Alias NameHDL delipidation therapy (Lipid Sciences)LSI-S955
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol binding agentHDL cholesterol modulators
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLipid Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipid Sciences
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A